Bridging the Gap From Research to Skin Cancer Prevention
The journey from groundbreaking research to effective medical treatments can be long and complex. This blog explores a promising “bench-to-bedside” approach. It connects the science of aging and skin cell behaviour with a potential preventive treatment for squamous cell skin cancer, a common type of skin cancer.
What is Squamous Cell Carcinoma?
Firstly, it’s essential to understand that SCC often begins as actinic keratoses (AKs). Actinic keratoses are rough, scaly patches on the skin caused by excessive exposure to ultraviolet (UV) radiation. Essentially, SCC starts as a growth of cells called squamous cells in the middle and outer layers of the skin. If left untreated, these lesions can evolve into SCC. Thus, the progression from AKs to SCC underscores the importance of early detection and intervention.
Recent Advances in SCC Research
1. Genetic and Molecular Insights:
Initially, recent research has provided deeper insights into the genetic mutations and molecular pathways involved in the development of squamous cell cancers (SCC). Specifically, key mutations in genes such as TP53, CDKN2A, and NOTCH1 have been identified, offering potential targets for new therapeutic interventions. Therefore, understanding these molecular mechanisms is essential for developing targeted therapies that can effectively treat SCC.
2. Immunotherapy:
Moreover, immunotherapy has revolutionized cancer treatment, and skin cancers, including SCC, are no exception. For example, immune checkpoint inhibitors, such as pembrolizumab and cemiplimab, have shown promise in treating advanced SCC. Consequently, these therapies work by enhancing the body’s immune response against cancer cells. It offers a new line of defense for patients with metastatic or unresectable SCC.
3. Photodynamic Therapy (PDT):
Additionally, PDT involves the application of a photosensitizing agent to the skin, followed by exposure to a specific wavelength of light. This treatment has shown effectiveness in treating early-stage SCC and AKs, providing a non-invasive option for patients. Hence, ongoing research aims to optimize PDT protocols and improve its efficacy.
4. Artificial Intelligence and Early Detection:
Furthermore, the integration of artificial intelligence (AI) in dermatology has the potential to revolutionize early detection and diagnosis of SCC. AI algorithms, trained on vast datasets of skin images, can assist doctors in identifying suspicious lesions with high accuracy. As a result, early detection through AI can lead to timely interventions, reducing the risk of SCC progression.
The Science Behind Skin Aging and Cutaneous Squamous Cell Carcinoma
For many years, we have known that UVB radiation from the sun causes DNA damage in skin cells. DNA damage can accumulate over time and lead to skin cancer. Interestingly, patients with basal cell carcinoma (BCC) are at an increased risk of developing cutaneous squamous cell carcinoma (cSCC). Furthermore, new research highlights the crucial role of the insulin-like growth factor 1 (IGF-1) and its receptor (IGF-1R) in how skin cells respond to UVB exposure. This pathway is particularly active in young skin, helping to repair DNA damage and prevent the formation of cancerous cells. However, as skin ages, the levels of IGF-1 decrease, leading to improper responses to UVB damage, allowing mutated cells to proliferate and potentially become cancerous. Additionally, cancer cells differ from normal cells in that they can evade the immune system, making it harder for the body to detect and destroy them.
Linking Aging, UVB Exposure, and Skin Cancer Risk Factors
Firstly, it’s well established that UVB radiation is a major factor in skin cancer development. Notably, SCC can spread to lymph nodes, making the assessment of lymph node involvement crucial for staging and treatment. Therefore, risk factors associated with UVB exposure and aging include prolonged sun exposure, fair skin, and genetic predispositions. Interestingly, the risk of developing skin cancer increases with age, with most cases diagnosed after age 60. This increase is partly due to a decline in the skin’s ability to repair DNA damage over time. Consequently, most squamous cell carcinomas of the skin can be prevented by checking the skin. It often starts by checking new growths or changes in moles, freckles, bumps, and birthmarks, and by protecting the skin from UV radiation. Additionally, recent studies have shown that aging skin has more senescent (aged and non-dividing) fibroblasts, which produce less IGF-1. This reduction leads to a weakened IGF-1R response in skin cells, resulting in poor handling of UVB-induced DNA damage and a higher risk of cancer.
New Therapeutic Approaches: Surgical Excision
Moreover, research has shown that restoring IGF-1 levels in aged skin can correct these faulty UVB responses. In experiments, injecting IGF-1 into the skin of older individuals before UVB exposure restored proper DNA repair mechanisms and reduced the risk of cancerous changes. This finding opens the door to new preventive treatments for SCC, particularly in older adults. Consequently, these new therapies are crucial for managing invasive squamous cell carcinoma, as they offer potential for noninvasive imaging techniques and systemic treatment modalities.
Innovative Treatments: Dermabrasion and Fractionated Laser Resurfacing
Additionally, two promising treatments, dermabrasion and fractionated laser resurfacing (FLR), have been studied for their ability to rejuvenate aging skin and restore its proper response to UVB damage. While these methods are effective, surgical excision remains the gold standard for treating cutaneous squamous cell carcinoma, effectively curing the majority of cases. For instance, dermabrasion, which involves removing the top layers of skin, has been shown to reduce the number of senescent fibroblasts and increase IGF-1 levels, making the skin respond more like that of a younger person. Similarly, FLR, a less invasive procedure, has shown comparable results, offering a practical and effective way to prevent skin cancer in the elderly.
Conclusion and Future Directions
In conclusion, these findings suggest a new paradigm in skin cancer prevention. By understanding the biological changes in aging skin and how they contribute to cancer risk, we can develop targeted treatments that not only make the skin look younger but also protect it from cancer. Therefore, these treatments could also offer significant benefits for solid organ transplant recipients, who are at increased risk for cutaneous squamous cell carcinoma (cSCC). Ongoing research will continue to refine these approaches, potentially combining them with other preventive strategies to offer even greater protection against SCC.
As these treatments become more widely available, they could significantly reduce the incidence of skin cancer, particularly in high-risk older populations. This represents an exciting step forward in the fight against skin cancer, combining scientific insight with practical, effective therapies.
Reference: